Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
已完结10由 Holly 发布于 2025/1/13 10:47:58
DOI:10.1016/s2213-2600(24)00324-2
作者:Dave Singh, Christopher E Brightling, Klaus F Rabe, MeiLan K Han, Stephanie A Christenson, M Bradley Drummond, Alberto Papi, Ian D Pavord, Nestor A Molfino, Gun Almqvist, Ales Kotalik, ?sa Hellqvist,
文献类型:期刊论文
补充材料:只需要正文